SPIA
JAZZ icon

Steward Partners Investment Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History

Steward Partners Investment Advisory’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
+365
New +$63.8K ﹤0.01% 2602
2025
Q4 		– Sell
-96
Closed -$12.7K – 4397
2025
Q3 		$12.7K Sell
96
-6
-6% -$720 ﹤0.01% 3299
2025
Q2 		$10.8K Sell
102
-6
-6% -$652 ﹤0.01% 3178
2025
Q1 		$13.4K Hold
108
– – ﹤0.01% 2968
2024
Q4 		$13.3K Sell
108
-219
-67% -$25.8K ﹤0.01% 2976
2024
Q3 		$36.4K Buy
327
+323
+8,075% +$35.4K ﹤0.01% 2398
2024
Q2 		$427 Hold
4
– – ﹤0.01% 3484
2024
Q1 		$482 Buy
+4
New +$490 ﹤0.01% 3428
2023
Q3 		– Sell
-6
Closed -$744 – 3415
2023
Q2 		$744 Sell
6
-18
-75% -$2.42K ﹤0.01% 3161
2023
Q1 		$3.51K Hold
24
– – ﹤0.01% 2895
2022
Q4 		$3.82K Hold
24
– – ﹤0.01% 2861
2022
Q3 		$3K Hold
24
– – ﹤0.01% 2943
2022
Q2 		$4K Hold
24
– – ﹤0.01% 2838
2022
Q1 		$4K Sell
24
-7
-23% -$1.02K ﹤0.01% 2956
2021
Q4 		$4K Sell
31
-100
-76% -$13.1K ﹤0.01% 2891
2021
Q3 		$17K Hold
131
– – ﹤0.01% 2392
2021
Q2 		$23K Sell
131
-113
-46% -$19.6K ﹤0.01% 4921
2021
Q1 		$40.1K Buy
244
+120
+97% +$19.7K ﹤0.01% 2098
2020
Q4 		$20K Sell
124
-35
-22% -$5.21K ﹤0.01% 2060
2020
Q3 		$23K Buy
159
+35
+28% +$4.34K ﹤0.01% 1838
2020
Q2 		$14K Sell
124
-8
-6% -$885 ﹤0.01% 1901
2020
Q1 		$13K Hold
132
– – ﹤0.01% 1757
2019
Q4 		$19K Sell
132
-7
-5% -$953 ﹤0.01% 1785
2019
Q3 		$17K Hold
139
– – ﹤0.01% 1781
2019
Q2 		$19K Buy
+139
New +$18.7K ﹤0.01% 1727
2018
Q4 		– Sell
-191
Closed -$32K – 1470
2018
Q3 		$32K Buy
191
+5
+3% +$860 ﹤0.01% 1362
2018
Q2 		$32K Buy
186
+110
+145% +$18K ﹤0.01% 1275
2018
Q1 		$11K Buy
+76
New +$11.1K ﹤0.01% 1544

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Steward Partners Investment Advisory's JAZZ Position: Q1 2026 in Review

Steward Partners Investment Advisory opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 365 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #2602 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in JAZZ as recently as Q3 2025.

Steward Partners Investment Advisory first reported a position in JAZZ in Q1 2018 and has held it in 28 quarters since. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Steward Partners Investment Advisory held 365 shares of Jazz Pharmaceuticals worth $69K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Steward Partners Investment Advisory position in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2602 holding.
  • Steward Partners Investment Advisory first reported a position in Jazz Pharmaceuticals in Q1 2018 and has held it in 28 quarters since.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.